Wall Street brokerages expect Synopsys (NASDAQ:SNPS) to post $774.77 million in sales for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Synopsys’ earnings. The highest sales estimate is $779.00 million and the lowest is $767.50 million. Synopsys posted sales of $680.07 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 13.9%. The business is expected to announce its next quarterly earnings results on Wednesday, May 16th.
On average, analysts expect that Synopsys will report full-year sales of $774.77 million for the current year, with estimates ranging from $2.94 billion to $2.96 billion. For the next financial year, analysts expect that the company will post sales of $3.12 billion per share, with estimates ranging from $3.10 billion to $3.14 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Synopsys.
Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, February 21st. The semiconductor company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.00 by $0.10. Synopsys had a net margin of 1.63% and a return on equity of 6.72%. The firm had revenue of $769.40 million for the quarter, compared to analysts’ expectations of $750.43 million. During the same period in the previous year, the business earned $0.94 earnings per share. Synopsys’s revenue for the quarter was up 17.9% compared to the same quarter last year.
In other Synopsys news, EVP Joseph W. Logan sold 10,313 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $84.69, for a total transaction of $873,407.97. Following the sale, the executive vice president now owns 78,584 shares in the company, valued at approximately $6,655,278.96. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Steven Walske sold 4,545 shares of Synopsys stock in a transaction dated Wednesday, January 17th. The shares were sold at an average price of $90.12, for a total value of $409,595.40. Following the transaction, the director now directly owns 14,988 shares in the company, valued at approximately $1,350,718.56. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 29,245 shares of company stock worth $2,529,005. Corporate insiders own 1.84% of the company’s stock.
Large investors have recently added to or reduced their stakes in the business. Cerebellum GP LLC purchased a new position in Synopsys during the 4th quarter valued at about $124,000. Robecosam AG grew its stake in Synopsys by 69.2% during the 4th quarter. Robecosam AG now owns 2,200 shares of the semiconductor company’s stock valued at $188,000 after acquiring an additional 900 shares in the last quarter. Calton & Associates Inc. purchased a new position in Synopsys during the 4th quarter valued at about $217,000. IBM Retirement Fund purchased a new position in Synopsys during the 4th quarter valued at about $201,000. Finally, Conning Inc. purchased a new position in Synopsys during the 4th quarter valued at about $205,000. 90.54% of the stock is currently owned by institutional investors.
Synopsys stock traded down $1.57 during midday trading on Friday, hitting $81.39. The company’s stock had a trading volume of 1,206,955 shares, compared to its average volume of 1,050,443. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 0.04. Synopsys has a 12 month low of $70.55 and a 12 month high of $94.80. The stock has a market cap of $12,305.51, a PE ratio of 92.49, a price-to-earnings-growth ratio of 5.33 and a beta of 1.09.
ILLEGAL ACTIVITY WARNING: This report was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3336214/zacks-analysts-expect-synopsys-snps-will-post-quarterly-sales-of-774-77-million.html.
Synopsys, Inc provides electronic design automation (EDA) software products used to design and test integrated circuits (ICs). It offers Galaxy Design platform that offers IC design solutions; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.